Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Neuroendocrine Tumors 532 Pituitary Neoplasms 188 Multiple Endocrine Neoplasia Type 1 187 Thyroid Cancer, Papillary 178 Pheochromocytoma 153 Carcinoma, Neuroendocrine 140 Thyroid Neoplasms 130 Neoplasms 107 Paraganglioma 99 Carcinoid Tumor 99 Adrenocortical Carcinoma 92 Thyroid Carcinoma, Anaplastic 82 Pancreatic Neoplasms 69 Neoplasm Metastasis 67 Insulinoma 61 Adrenal Gland Neoplasms 61 Carcinoma, Medullary 59 Gastro-enteropancreatic neuroendocrine tumor 58 Adenocarcinoma, Follicular 58 Carcinoma, Non-Small-Cell Lung 57 Breast Neoplasms 56 Adenoma, Islet Cell 56 Lung Neoplasms 50 Sarcoma 49 Colorectal Neoplasms 49 Carcinoma, Renal Cell 49 Melanoma 47 Small Cell Lung Carcinoma 45 Prostatic Neoplasms 44 Head and Neck Neoplasms 43

Interventions

lenvatinib 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Cancer Metastatic × Endocrine × Clear all

NCT03732495 2022-03-29

LENVOS

Centre Leon Berard

Phase 2 Unknown

EndocrineHead & Neck

Thyroid Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡